22-37734501-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039141.3(TRIOBP):​c.4165C>A​(p.Leu1389Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,609,754 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00061 ( 10 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.362

Publications

4 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003253758).
BP6
Variant 22-37734501-C-A is Benign according to our data. Variant chr22-37734501-C-A is described in ClinVar as Benign. ClinVar VariationId is 227125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00581 (885/152272) while in subpopulation AFR AF = 0.02 (831/41556). AF 95% confidence interval is 0.0189. There are 6 homozygotes in GnomAd4. There are 425 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.4165C>A p.Leu1389Ile missense_variant Exon 9 of 24 ENST00000644935.1 NP_001034230.1 Q9H2D6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.4165C>A p.Leu1389Ile missense_variant Exon 9 of 24 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1
TRIOBPENST00000344404.10 linkn.*3648C>A non_coding_transcript_exon_variant Exon 7 of 22 2 ENSP00000340312.6 H7BXW4
TRIOBPENST00000344404.10 linkn.*3648C>A 3_prime_UTR_variant Exon 7 of 22 2 ENSP00000340312.6 H7BXW4

Frequencies

GnomAD3 genomes
AF:
0.00579
AC:
881
AN:
152154
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0199
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00133
AC:
317
AN:
239056
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.0179
Gnomad AMR exome
AF:
0.00131
Gnomad ASJ exome
AF:
0.000104
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000931
Gnomad OTH exome
AF:
0.000690
GnomAD4 exome
AF:
0.000606
AC:
883
AN:
1457482
Hom.:
10
Cov.:
36
AF XY:
0.000541
AC XY:
392
AN XY:
724754
show subpopulations
African (AFR)
AF:
0.0183
AC:
611
AN:
33434
American (AMR)
AF:
0.00136
AC:
60
AN:
44178
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25956
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.0000350
AC:
3
AN:
85636
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51992
Middle Eastern (MID)
AF:
0.000868
AC:
5
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000954
AC:
106
AN:
1110668
Other (OTH)
AF:
0.00163
AC:
98
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00581
AC:
885
AN:
152272
Hom.:
6
Cov.:
32
AF XY:
0.00571
AC XY:
425
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0200
AC:
831
AN:
41556
American (AMR)
AF:
0.00216
AC:
33
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68018
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00275
Hom.:
3
Bravo
AF:
0.00646
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0169
AC:
64
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.00163
AC:
196
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1389Ile in Exon 09 of TRIOBP: This variant is not expected to have clinical s ignificance because it has been identified in 1.7% (53/3102) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs144175566). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.6
DANN
Benign
0.93
DEOGEN2
Benign
0.022
T;T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.42
.;T
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
-0.36
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.70
N;.
REVEL
Benign
0.0080
Sift
Uncertain
0.010
D;.
Sift4G
Benign
0.28
T;.
Polyphen
0.34
B;B
Vest4
0.12
MVP
0.19
MPC
0.19
ClinPred
0.0028
T
GERP RS
-0.59
Varity_R
0.053
gMVP
0.032
Mutation Taster
=98/2
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144175566; hg19: chr22-38130508; API